Hair Relaxer Uterine Cancer Lawsuits
Women who regularly used chemical hair relaxers and were diagnosed with uterine cancer may be entitled to significant compensation.
Overview
Recent studies have linked chemical hair relaxers to an increased risk of uterine cancer, endometrial cancer, and other hormone-related cancers in women who used these products regularly.
Key Facts
- Active Cases: 10,168 lawsuits in MDL as of May 2025
- Defendants: L'Oréal, Revlon, and other manufacturers
- First Trials: Scheduled for 2027
- Primary Condition: Uterine/endometrial cancer
Who Qualifies?
You may be eligible if you:
- Used chemical hair relaxers regularly (4+ times per year)
- Were diagnosed with uterine or endometrial cancer
- Used products for an extended period
- Are between ages 35-70
Scientific Evidence
- NIH studies show increased cancer risk with regular use
- Chemical ingredients include formaldehyde and other carcinogens
- Higher risk for women who started using products at young age
Eligible Diagnoses
- Uterine cancer
- Endometrial cancer
- Ovarian cancer
- Breast cancer (in some cases)
Average Settlement Potential
Average settlement amounts vary based on severity and individual circumstances. While trials are scheduled for 2027, early settlements may be possible. The MDL continues to grow rapidly, indicating strong evidence against manufacturers.
How to File
If you used chemical hair relaxers regularly and were diagnosed with cancer, you may qualify to file a claim for possible compensation. Contact us today for a free, confidential case evaluation. No upfront costs.
Time May Be Limited
Filing deadlines may apply. Don't wait to find out if you qualify for compensation.
Get Your Free Case Review
Find out if you qualify for compensation. No upfront costs.
